Obio Technology Shanghai Corp. Ltd. is a biotechnology company. It focuses on providing gene therapy vector development, gene function research, CRO services such as drug target and efficacy research, and CDMO services such as process development and testing, IND-CMC pharmaceutical research, and GMP production of clinical samples for the research and development of genetic drugs. The company was founded on March 5, 2013 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company